- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01323868
Endogenous Endophthalmitis in the Inpatient Setting
Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes
Study Overview
Status
Conditions
Detailed Description
Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis).
Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Positive intraocular infection
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Visual acuity
Time Frame: 2 wk
|
2 wk
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Theodore Leng, Stanford University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU-03232011-7621
- IRB-18785
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endophthalmitis
-
Suzan A RattanAl-Kindy College of MedicineCompletedEndophthalmitis Postoperative
-
National University of MalaysiaSanten Pharmaceutical Co., Ltd.Unknown
-
University Hospital, GrenobleUnknown
-
Moorfields Eye Hospital NHS Foundation TrustKing's College London; University College, LondonRecruitingEndophthalmitis Postoperative AcuteUnited Kingdom
-
Shahid Beheshti University of Medical SciencesCompletedEndophthalmitis | Prophylaxy of Post Traumatic Endophthalmitis | Bacterial EndophthalmitisIran, Islamic Republic of
-
Ospedale Sacra Famiglia - Fatebenefratelli ErbaCompletedEndophthalmitis Following Cataract SurgeryItaly
-
National University of MalaysiaSanten Pharmaceutical Co., Ltd.UnknownEndophthalmitis PostoperativeMalaysia
-
Novartis PharmaceuticalsNot yet recruiting
-
Centre Hospitalier Universitaire DijonCompletedPost-operative EndophthalmitisFrance
-
University of Campinas, BrazilRecruitingEndophthalmitis | Moxifloxacin | Open Globe Injury | Post-Traumatic EndophthalmitisBrazil